Burning Rock Biotech Limited (BNR) Misses Q2 EPS by RMB 1.20

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q2 EPS of (RMB2.50), RMB1.20 worse than the analyst estimate of (RMB1.30). Revenue for the quarter came in at RMB130.8 million versus the consensus estimate of RMB150.5 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
• Sypris Solutions (SYPR) Reports Q2 Loss of $0.14